| As filed with the Securities and Exchange Commission on _________, 2018 | Registration No. 333- |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM F-6
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 FOR
AMERICAN DEPOSITARY SHARES EVIDENCED BY AMERICAN DEPOSITARY RECEIPTS
Washington, D.C. 20549
Bioceres S.A.
(Exact name of issuer of deposited securities as specified in its charter)
_____________________
Not Applicable
(Translation of issuer’s name into English)
_____________________
Republic of Argentina
(Jurisdiction of incorporation or organization of issuer)
_____________________
Deutsche Bank Trust Company Americas
(Exact name of depositary as specified in its charter)
60 Wall Street
New York, New York 10005
+1 (212) 250-9100
(Address, including zip code, and telephone number, including area code, of depositary’s principal executive offices)
_____________________
Cogency Global Inc.
10 E. 40th Street, 10th Floor
New York, NY 10016
Tel.: +1 (212) 947-7200
(Address, including zip code, and telephone number, including area code, of agent for service)
_____________________
Copies to:
Conrado Tenaglia, Esq. Matthew S. Poulter, Esq. Linklaters LLP 1345 Avenue of the Americas New York, New York 10105 Phone: +1 (212) 903-9000 Fax: +1 (212) 903-9100 | Francis Fitzherbert-Brockholes, Esq. White & Case LLP 5 Old Broad Street London EC2N 1DW United Kingdom +(44) 20 7532-1400 Fax: +(44) 20 7532-1001 |
_____________________
| It is proposed that this filing become effective under Rule 466: | o immediately upon filing. o on (Date) at (Time) |
If a separate registration statement has been filed to register the deposited shares, check the following box : x
_____________________
CALCULATION OF REGISTRATION FEE
Title of each class of Securities to be registered | Amount to be registered | Proposed maximum aggregate price per unit (1) | Proposed maximum aggregate offering price (2) | Amount of registration fee |
| American Depositary Shares, each representing one ordinary share of Bioceres S.A. | 100,000,000 American Depositary Shares | $0.05 | $5,000,000 | $622.50 |
| 1 | For the purpose of this table only the term "unit" is defined as one American Depositary Share. |
| 2 | Estimated solely for the purpose of calculating the registration fee. Pursuant to Rule 457(k), such estimate is computed on the basis of the maximum aggregate fees or charges to be imposed in connection with the issuance of American Depositary Shares. |
This registration statement may be executed in any number of counterparts, each of which shall be deemed an original, and all of such counterparts together shall constitute one and the same instrument.
PART I
INFORMATION REQUIRED IN PROSPECTUS
The prospectus consists of the proposed form of American Depositary Receipt (“Receipt”) included as Exhibit A to the form of Deposit Agreement filed as Exhibit (a) to this registration statement and is incorporated herein by reference.
Item 1. DESCRIPTION OF SECURITIES TO BE REGISTERED
Required Information | Location in Form of Receipt Filed Herewith as Prospectus | |||||
11. | Name of depositary and address of its principal executive office | Face of Receipt – introductory paragraph | ||||
22. | Title of Receipts and identity of deposited securities | Face of Receipt – top center | ||||
Terms of Deposit: | ||||||
| (i) | The amount of deposited securities represented by one American Depositary Share (“ADS”) | Face of Receipt – upper right corner | ||||
| (ii) | The procedure for voting the deposited securities | Reverse of Receipt – Articles 15 and 16 | ||||
| (iii) | The procedure for collecting and distributing dividends | Reverse of Receipt – Articles 14 and 15 | ||||
| (iv) | The procedures for transmitting notices, reports and proxy soliciting material | Face of Receipt – Article 13; Reverse of Receipt – Articles 15 and 16 | ||||
| (v) | The sale or exercise of rights | Reverse of Receipt – Articles 14 and 15 | ||||
| (vi) | The deposit or sale of securities resulting from dividends, splits or plans of reorganization | Face of Receipt – Articles 3, 7 and 10; Reverse of Receipt – Articles 14 and 17 | ||||
| (vii) | Amendment, extension or termination of the deposit arrangements | Reverse of Receipt – Articles 21 and 22 (no provision for extension) | ||||
| (viii) | The rights of holders of Receipts to inspect the books of the depositary and the list of holders of Receipts | Face of Receipt – Article 13 | ||||
| (ix) | Restrictions upon the right to transfer or withdraw the underlying securities | Face of Receipt – Articles 2, 3, 4, 7, 9, 10 and 11; Reverse of Receipt – Article 22 | ||||
| (x) | Limitation on the depositary’s liability | Face of Receipt – Article 7 and 11; Reverse of Receipt – Articles 16, 17, 18 and 19 | ||||
33. | Fees and charges that a holder of Receipts may have to pay, either directly or indirectly | Face of Receipt – Article 10 | ||||
Item 2. AVAILABLE INFORMATION
Bioceres S.A. (the “Company”) is subject to the periodic reporting requirements of the United States Securities Exchange Act of 1934, as amended, and, accordingly, files certain reports with, and furnishes certain reports to, the Commission. These reports can be retrieved from the Commission’s internet website (www.sec.gov) and can be inspected and copied at the public reference facilities maintained by the Commission at 100 F Street, N.E., Washington D.C. 20549.
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 3. EXHIBITS
(a) | Form of Deposit Agreement, by and among the Company, Deutsche Bank Trust Company Americas, as depositary (the “Depositary”), and all holders and beneficial owners from time to time of ADSs issued thereunder (“Deposit Agreement”). — Filed herewith as Exhibit (a). |
(b) | Any other agreement to which the Depositary is a party relating to the issuance of the ADSs registered hereunder or the custody of the deposited securities represented thereby. — Not applicable. |
(c) | Every material contract relating to the deposited securities between the Depositary and the issuer of the deposited securities in effect at any time within the last three years. — Not applicable. |
(d) | Opinion of White & Case LLP, counsel to the Depositary, as to the legality of the securities to be registered. — Filed herewith as Exhibit (d). |
(e) | Certification under Rule 466. — Not applicable. |
(f) | Powers of attorney for certain officers and directors of the Company. — Set forth on the signature pages hereto. |
Item 4. UNDERTAKINGS
(a) | The Depositary hereby undertakes to make available at the principal office of the Depositary in the United States, for inspection by holders of the ADRs, any reports and communications received from the issuer of the deposited securities which are both (1) received by the Depositary as the holder of the deposited securities; and (2) made generally available to the holders of the underlying securities by the issuer. |
(b) | If the amount of fees charged is not disclosed in the prospectus, the Depositary undertakes to prepare a separate document stating the amount of any fee charged and describing the service for which it is charged and to deliver promptly a copy of such fee schedule without charge to anyone upon request. The Depositary undertakes to notify each registered holder of an ADR thirty (30) days before any change in the fee schedule. |
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that all the requirements for filing on Form F-6 are met and has duly caused this registration statement on Form F-6 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New York, on January 23, 2018.
| Legal entity created by the form of Deposit Agreement for the issuance of Receipts for ordinary shares, par value Ps. 1 per share of Bioceres S.A. | |
| Deutsche Bank Trust Company Americas, as Depositary |
| By: | /s/ Michael Fitzpatrick | ||
| Name: Michael Fitzpatrick | |||
Title: Vice President | |||
| By: | /s/ Beverly George | ||
| Name: Beverly George | |||
| Title: Vice President | |||
Pursuant to the requirements of the Securities Act of 1933, as amended, Bioceres S.A. certifies that it has reasonable grounds to believe that all the requirements for filing on Form F-6 are met and has duly caused this registration statement on Form F-6 to be signed on its behalf by the undersigned, thereunto duly authorized, in Rosario, Argentina, on January 23, 2018.
Bioceres S.A. | |||
| By: | /s/ Federico Trucco | ||
Name: | Federico Trucco | ||
| Title: | Chief Executive Officer and Attorney-in-Fact | ||
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints each of Federico Trucco and Gloria Montaron Estrada, his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any or all amendments (including post-effective amendments) to this registration statement and any and all related registration statements pursuant to Rule 462(b) of the Securities Act and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Under the requirements of the Securities Act, this Registration Statement has been signed by the following persons on January 23, 2018, in the capacities indicated.
| Signature | Title | ||
| /s/ Federico Trucco | Chief Executive Officer (Principal Executive Officer) and Director | ||
| Name: Federico Trucco | |||
| /s/ Enrique López Lecube | Chief Financial Officer (Principal Financial Officer & Principal Accounting Officer) | ||
| Name: Enrique López Lecube | |||
| /s/ Marcelo Adolfo Carrique | Chairman of the Board | ||
| Name: Marcelo Adolfo Carrique | |||
| /s/ Cintia Guillermina Castagnino | Director | ||
| Name: Cintia Guillermina Castagnino | |||
| /s/ Matías Hugo Kugler | Director | ||
| Name: Matías Hugo Kugler | |||
| /s/ Santiago Sacerdote | Director | ||
| Name: Santiago Sacerdote | |||
| /s/ Manuel Alberto Sobrado | Director | ||
| Name: Manuel Alberto Sobrado | |||
| /s/ Ignacio Lartirigoyen | Director | ||
| Name: Ignacio Lartirigoyen | |||
| /s/ Aimar Dimo | Vice-Chairman | ||
| Name: Aimar Dimo | |||
| /s/ Carlos Popik | Director | ||
| Name: Carlos Popik |
SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES
Pursuant to the Securities Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of Bioceres S.A., has signed this registration statement in New York, New York, United States of America on January 23, 2018.
Cogency Global Inc. | |||
| By: | /s/ Melissa Tomelden_______________________________________________ | ||
| Name: | Melissa Tomelden | ||
Title: | Assistant Secretary on behalf of Cogency Global Inc. | ||
Index to Exhibits
| Exhibit | Document | ||
(a) | Form of Deposit Agreement | ||
| (d) | Opinion of White & Case LLP, counsel to the Depositary | ||